Via emailed media release:
Industry Sponsorship Leads to Bias in Reported Findings of Clinical Trials
Studies reporting the results of industry sponsored clinical trials present a more favourable picture of the effects of drugs and medical devices than those reporting on non-industry sponsored trials, according to a new Cochrane systematic review. The researchers call for a rethink of the way that industry bias is handled in medical guidelines and reviews.
* * *
The researchers carried out a systematic review of 48 studies on drugs and medical devices. The drugs and devices being studied were prescribed for a wide range of different diseases and conditions, from heart disease to psychiatric conditions, and were compared to placebos or other treatments. Studies sponsored by industry reported greater benefits and fewer harmful side effects compared to studies that were not sponsored by industry. Papers describing industry sponsored studies presented more favourable overall conclusions, and results and conclusions sections in these papers were less likely to agree.
The book we received an email about three days later:
Because, you know, if it can restore its image, everything will be hunky dory. A former president of Pfizer says so.